NDC 86147-004 - TONICPET 5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86147-004
- Package NDCs from labels
- 86147-004-01
- Manufacturer
- Groupe Cyrenne Inc.
- Effective date
- 2025-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TONICPET 5 - Groupe Cyrenne Inc. | Groupe Cyrenne Inc. | 2025-11-20 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86147-004-01 | TONICPET 5 | 20 g in 1 BOTTLE | PELLET | 20 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Major Pharmaceuticals | 33ad1eb2-1f05-461c-b01d-82dee4231556 | 2026-02-11 | Warnings, Adverse reactions | 660YQ98I10 |
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POKONZA potassium chloride | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 2d938cbf-27aa-4f9c-a582-5564d3b72465 | 2026-01-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 755a4a08-04ff-d7d1-a6fc-b8aeff3ae2c6 | 2026-01-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Advagen Pharma Limited | d528c0c1-b81f-4f7a-8518-e6911b23c3eb | 2026-01-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Lung Drainage | ANTIMONIUM ARSENICICUM, BRYONIA (ALBA), CAMPHORA, CARBO VEGETABILIS, CHELIDONIUM MAJUS, CHININUM MURIATICUM, CUPRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HAEMOPHILUS INFLUENZAE B, IPECACUANHA, KALI MURIATICUM, LOBELIA PURPURESCENS, LUNG (SUIS), MYCOPLASMA PNEUMONIAE, MYCOPLASMA PNEUMONIAE DNA, OXYGENIUM, PHOSPHORUS, PNEUMOCOCCINUM, SENEGA OFFICINALIS, STANNUM METALLICUM, VERATRUM VIRIDE | Deseret Biologicals, Inc. | fd109172-46c3-444e-9fa0-124f785c3fb5 | 2026-01-09 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvPAK | f32df7c0-33eb-e6d6-e053-2a95a90a2e8d | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Baxter Healthcare Corporation | 092ddee4-572d-4771-8d95-880cea01097e | 2026-01-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Flex Drops 2024 | FLEX DROPS | Professional Complementary Health Formulas | e857670f-de84-494e-9e81-80144792d1fa | 2026-01-08 | Warnings | 660YQ98I10 |
| Cell Salt Combination 8013 | CELL SALT COMBINATION | Professional Complementary Health Formulas | b3a33345-3c3d-4f86-ae4d-757c65fd1ed3 | 2026-01-08 | Warnings | 660YQ98I10 |
| Lyme Nosode Drops 2128 | LYME NOSODE DROPS | Professional Complementary Health Formulas | c9fed770-938a-406b-ac95-593d1318ecce | 2026-01-08 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Advagen Pharma Limited | a9e9d134-55d0-47ae-925f-de07e7ffa4b8 | 2026-01-07 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Advagen Pharma Ltd. | f4497c26-da16-45b0-975d-81f2c2132704 | 2026-01-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23b10bd6-11bc-495e-bb05-ec332a9b3f21 | 2026-01-06 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | BPI Labs LLC | 1ea4345e-f8bb-4d41-9003-c87b21169d7c | 2026-01-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Lung Drainage | ANTIMONIUM ARSENICICUM, BRYONIA (ALBA), CAMPHORA, CARBO VEGETABILIS, CHELIDONIUM MAJUS, CHININUM MURIATICUM, CUPRUM METALLICUM, GELSEMIUM SEMPERVIRENS, HAEMOPHILUS INFLUENZAE B, IPECACUANHA, KALI MURIATICUM, LOBELIA PURPURESCENS, LUNG (SUIS), MYCOPLASMA PNEUMONIAE, MYCOPLASMA PNEUMONIAE DNA, OXYGENIUM, PHOSPHORUS, PNEUMOCOCCINUM, SENEGA OFFICINALIS, STANNUM METALLICUM, VERATRUM VIRIDE | Deseret Biologicals, Inc. | 64a99cd3-341a-44ec-b4eb-c06982e6d414 | 2026-01-05 | Warnings | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.